For Sobi Media News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from For sobi media. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In For Sobi Media Today - Breaking & Trending Today

Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023 -April 02, 2024 at 05:07 am EDT

English

. ....

United States , Gerard Tobin , Sobi Investor Relations Team , Sobi Task Force On Financial Disclosures , Swedish Annual Accounts Act , Task Force , Climate Related Financial Disclosures , Sustainability Report , Swedish Annual Report , European Single Electronic Format , North America , Middle East , For Sobi Media ,

Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP -March 25, 2024 at 03:13 am EDT

Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP -March 25, 2024 at 03:13 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Sobi Investor Relations Team , Us Food Drug Administration , European Medicines Agency , About Doptelet , Drug Administration , North America , Middle East , For Sobi Media ,

Sobi to present new data at EAHAD 2024

Sobi® will present new data at the 17th European Association of Haemophilia and Allied Disorders conference in Frankfurt from 6-9 February 2024. The studies that will be presented support Sobi s. ....

United States , Saudi Arabia , New Zealand , Lydia Abad Franch , European Association Of Haemophilia , European Medicines Agency , Sobi Investor Relations Team , European Commission , Allied Disorders , Chief Medical Officer , Alfa Prophylaxis Outcomes , European Patients From , Previously Treated Patients , Efanesoctocog Alfa , Kids Study , Tolerance Induction , Recombinant Factor , Final Data , Chart Review Study , World Effectiveness , Secondary Paediatric Analysis , Month French , Real World Effectiveness , Surgical Haemostasis , Month Prospective , Interim Analysis ,

Sobi's Chairman of the Board resigns due to health reasons

Swedish Orphan Biovitrum AB s Chairman of the Board Bo Jesper Hansen resigns, at his own request and with immediate effect, from his position as Chairman of the Board and board member due to. ....

United States , Bo Jesper Hansen , Annette Clancy , Bo Jesper , Tobias Cottmann , Sobi Investor Relations Team , Swedish Orphan Biovitrum , Jesper Hansen , For Sobi Media ,

Invitation: Sobi's Q3 2023 report -October 18, 2023 at 09:04 am EDT

Invitation: Sobi s Q3 2023 report

18 October, 2023 15:00

Sobi plans to publish its report for the third quarter of 2023 on 30 October 2023 at. ....

United Kingdom , United States , Sobi Investor Relations Team , North America , Middle East , For Sobi Media ,